Alkeus Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2464 Massachusetts Ave Ste 314, Cambridg...Phone Number
(800) 287-2755Website
www.alkeuspharma.comRevenue
$9.5 MillionIndustry
About Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc. is a biopharmaceutical company focused on preserving sight for individuals affected by retinal diseases, particularly Stargardt disease and geographic atrophy. Their innovative oral therapy aims to prevent the accumulation of toxic vitamin A dimers in the retina, addressing a significant unmet need in these conditions. Alkeus is committed to advancing clinical trials and bringing the first therapeutic options to patients suffering from these rare genetic disorders. Recently, they have joined Tarsus Pharmaceuticals to further enhance their mission and impact in the field of retinal disease.Explore more
Alkeus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alkeus Pharmaceuticals
Compare insights from companies similar to Alkeus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alkeus Pharmaceuticals Tech Stack
A closer look at the technologies used by Alkeus Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alkeus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Alkeus Pharmaceuticals, Inc. is a biopharmaceutical company focused on preserving sight for individuals affected by retinal diseases, particularly Stargardt disease and geographic atrophy. Their innovative oral therapy aims to prevent the accumulation of toxic vitamin A dimers in the retina, addressing a significant unmet need in these conditions.... Read More
